-
Gynecology Collaboration and Licensing Agreement Trends Analysis Report 2025 | Access to 150 Deals Signed Since 2016 - Upfront, Milestone, Royalties by Company A-Z, Therapy Focus and Technology Type - ResearchAndMarkets.com
02 Jul 2025 14:12 GMT
… Allakos
Allegheny Technologies
Altavant Sciences
Amag Pharmaceuticals
American Dental Association
Amring … ;s Hospital
California Cryobank
Cancer Prevention and Research Institute of … Medical
Genomic Prediction
German Cancer Research Center
Gilead Sciences
…
-
Global Preterm Birth Prevention Market 2025-2034: Growth Drivers, Key Segments, and Emerging Trends
02 Jun 2025 12:10 GMT
… QIAGEN N.V., Ferring Pharmaceuticals, AMAG Pharmaceuticals, and others. These key industry … -report
Next-Generation Gynecological Cancer Diagnostics Global Market Report … #47;next-generation-gynecological-cancer-diagnostics-global-market-report
About …
-
AMAG Pharmaceuticals: Q1 Earnings Insights
11 May 2020 12:09 GMT
Shares of AMAG Pharmaceuticals (NASDAQ:AMAG) remained … the company for now.
AMAG Pharmaceuticals hasn't issued … 19.25%
Company Profile
AMAG Pharmaceuticals Inc primarily uses its … that assist in identifying cancerous tumors. The company recently …
-
AMAG Pharmaceuticals Appoints Scott Myers as President and Chief Executive Officer
28 Apr 2020 11:00 GMT
… 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today … company focused on metastatic bladder cancer. Prior to joining Rainier, … ‐looking statements. AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. AMAG …
-
AMAG Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee Meeting to Discuss the Results of the Makena PROLONG Trial
29 Oct 2019 11:03 GMT
… , 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) … problems, breast cancer or other hormone-sensitive cancers, or history … com. AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals Contact: …
-
AMAG Pharmaceuticals Announces the Publication of the PROLONG Trial Evaluating 17-OHPC in the American Journal of Perinatology
25 Oct 2019 14:19 GMT
… . 25, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced … clotting problems, breast cancer or other hormone-sensitive cancers, or history of … in the forward-looking statements. AMAG Pharmaceuticals® and the logo are registered …
-
Bringing AMAG Pharmaceuticals Back To Life
22 Oct 2019 15:38 GMT
… that, under the right circumstances, AMAG pharmaceuticals' (AMAG) shares could … value of AMAG Company background AMAG pharmaceuticals was incorporated in 1981. The … maternal health, anemia management, and cancer supportive care. AMAG products include …
-
AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP
08 Oct 2019 12:00 GMT
… as Chair of the American Cancer Society Initiative for New England … (CEOs against Cancer) and as a Special Advisor … www.amagpharma.com. AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. Forward …
-
AMAG Pharmaceuticals Announces FDA Approval of Vyleesi™ (Bremelanotide Injection) for Acquired, Generalized Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
21 Jun 2019 21:23 GMT
… 21, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced … trademarks of AMAG Pharmaceuticals, Inc. Vyleesi™ is a trademark of AMAG Pharmaceuticals, Inc. … other emotional stimuli in breast cancer survivors with and without distress …
-
AMAG Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update
07 May 2019 11:00 GMT
… clotting problems, breast cancer or other hormone-sensitive cancers, or history of … with a history of breast cancer. In clinical studies, vaginal … trademarks of AMAG Pharmaceuticals, Inc. VyleesiTM is a trademark of AMAG Pharmaceuticals, Inc. Makena …
About
© 1995-2025